QleanAir signs two new US cleanroom agreements totaling approximately $2.4 million USD, adding a specialty compounding partner and continuing work with a longstanding institutional customer
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Industri |
| Industri | Industriprodukter |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
QleanAir AB (publ), a leading provider of solutions for clean indoor air, has signed two new agreements with US healthcare customers for the construction of modular cleanrooms compliant with USP 797 and USP 800 standards. The agreements include a first cleanroom for a multi-state specialty compounding pharmacy operator, and a continued partnership with a longstanding institutional customer at a hospital in Texas. Both projects are scheduled to commence in 2026 and complete by the end of the first quarter of 2027.
QleanAir is dedicated to being an excellent partner through building and maintaining modular cleanrooms that exceed USP guidelines and maintain a compliant state of control.
The first agreement, valued at approximately $1.8 million USD, is for a sterile compounding fulfillment facility that includes a USP 797, USP 800, and cGMP-compliant microbiology laboratory. It marks the first QleanAir cleanroom for this customer, a multi-state specialty compounding pharmacy operator focused on personalized medicine, with operations across the Gulf South and the Midwest. The customer's parent organization operates in adjacent areas with significant cleanroom requirements, opening the door to a broader, multi-site partnership over time.
The second agreement, valued at approximately $551,000 USD, is for a USP 797 and USP 800 compliant compounding cleanroom at a hospital in Texas. The hospital is part of a large integrated healthcare system that QleanAir has supported across multiple sites, and the agreement extends a longstanding institutional relationship that has become a consistent source of repeat business.
Both cleanrooms are scheduled to begin construction in 2026 and complete by the end of the first quarter of 2027.
– “These two agreements reflect the breadth of our customer base in the United States. We are excited to begin a new partnership with a multi-state specialty compounding pharmacy operator that also has cleanroom needs across its parent organization, and we are honored to continue our work with a longstanding institutional customer that consistently turns to QleanAir for its compounding cleanroom needs” says Zachary Douglas, President of QleanAir Scandinavia Inc.